In vitro screening for drugs that inhibit cytochrome P450 enzymes is well established as a means for predicting potential metabolism-mediated drug interactions in vivo. Given that …
M Rowland, C Peck, G Tucker - Annual review of pharmacology …, 2011 - annualreviews.org
The application of physiologically-based pharmacokinetic (PBPK) modeling is coming of age in drug development and regulation, reflecting significant advances over the past 10 …
RT Di Giulio, DE Hinton - 2008 - taylorfrancis.com
When looking for a book on fish toxicology, you might find one that discusses the biochemical and molecular aspects, or one that focuses aquatic toxicology in general. You …
ZE Barter, MK Bayliss, PH Beaune… - Current drug …, 2007 - ingentaconnect.com
Reported predictions of human in vivo hepatic clearance from in vitro data have used a variety of values for the scaling factors human microsomal protein (MPPGL) and …
T Iwatsubo, N Hirota, T Ooie, H Suzuki… - Pharmacology & …, 1997 - Elsevier
As a new approach to predicting in vivo drug metabolism in humans, scaling of in vivo metabolic clearance from in vitro data obtained using human liver microsomes or …
MJ Mulvihill, A Cooke… - Future medicinal …, 2009 - Taylor & Francis
Background: The IGF-1 receptor (IGF-1R) has been implicated in the promotion of tumorigenesis, metastasis and resistance to cancer therapies. Therefore, this receptor has …
J Mordenti - Journal of pharmaceutical sciences, 1986 - Elsevier
Land mammals range in size from the 3-g shrew to the 3000-kg elephant. Despite this 10 6 range in weight, most land mammals have similar anatomy, physiology, biochemistry, and …
[引用][C]Prediction of human clearance of twenty-nine drugs from hepatic microsomal intrinsic clearance data: an examination of in vitro half-life approach and …
RS Obach - Drug Metabolism and Disposition, 1999 - ASPET